Association for Accessible Medicines
FDANonrulemakingFDA-2018-N-4087

FDA’s Proposed Current Good Manufacturing Practice Policies for Outsourcing Facilities: Considerations Regarding Access to Office Stock; Public Meeting.

RIN
Last modified
Jul 12, 2019
Comment window
closed 2594d ago
Association for Accessible Medicines filings
1

Activity

Association for Accessible Medicines filed 1 comment on this docket between Jul 12, 2019 and Jul 12, 2019. 0 other organizations filed here. The comment window closed 2594d ago.

What Association for Accessible Medicines filed (1)

Jul 12, 2019· Comment from Association for Accessible Medicines (AAM)· FDA-2018-N-4087-0004

Comments from The Association for Accessible Medicines (AAM) on behalf of our member companies, regarding FDA-2018-N-4087: Proposed Current Good Manufacturing Practice Policies for Outsourcing Facilities: Considerations Regarding Access to Office Stock; Public Meeting; Request for Comments.

Abstract

No abstract recorded.

View on regulations.gov →